J1599 HCPCS code: Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg
J1599 is the HCPCS Level II code for injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg. In 2023 Medicare paid an average of $83.79 per service for J1599 across 195,336 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 300 per day on DME suppliers. Medicare volume rose 30% from 2022 to 2023 (150,109 to 195,336 services). In 2024, 33 suppliers billed Medicare for J1599 (purchases), serving 87 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2011-01-01 |
| Last action effective | 2011-01-01 |
Who bills J1599 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 33 |
| Referring clinicians | 77 |
| Medicare beneficiaries | 87 |
| States with claims | 3 |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 144 | 499 |
| 2023 | 128 | 488 |
| 2024 | 33 | 87 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1599, 2022–2023
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 150,109 | 433 | $119.05 | $94.93 |
| 2023 | 195,336 | 606 | $105.23 | $83.79 |
States with the most J1599 services (2023)
| State | Services | Avg. paid |
|---|---|---|
| California | 44,553 | $55.08 |
| Tennessee | 40,511 | $54.71 |
| Alabama | 24,462 | $53.57 |
| Texas | 18,919 | $219.79 |
| Florida | 13,360 | $77.48 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 300 | Clinical: Data |
| outpatient hospital claims | 300 | Clinical: Data |
| practitioner claims | 300 | Clinical: Data |
Medicare policy articles for this code
- A52509: Intravenous Immune Globulin - Policy Article (CGS Administrators, LLC (DME MAC) Noridian Healthcare Solutions, LLC (DME MAC)) — mentions this code in its coding guidance
- A56718: Billing and Coding: Intravenous Immunoglobulin (IVIG) (Palmetto GBA (MAC - Part A, MAC - Part B))
- A57160: Billing and Coding: Immune Thrombocytopenia (ITP) Therapy (CGS Administrators, LLC (MAC - Part A, MAC - Part B))
- A57187: Billing and Coding: Immune Globulin Intravenous (IVIg) (Noridian Healthcare Solutions, LLC (MAC - Part A, MAC - Part B))
- A57554: Billing and Coding: Immune Globulins (WPS Insurance Corporation (MAC - Part A, MAC - Part B))
- A59105: Billing and Coding: Off-Label Use of Intravenous Immune Globulin (IVIG) (Wellpoint Federal (MAC - Part A, MAC - Part B))
Covered diagnoses (1,433 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| D69.3 | Immune thrombocytopenic purpura | 5 |
| D80.0 | Hereditary hypogammaglobulinemia | 5 |
| D80.2 | Selective deficiency of immunoglobulin A [IgA] | 5 |
| D80.3 | Selective deficiency of immunoglobulin G [IgG] subclasses | 5 |
| D80.4 | Selective deficiency of immunoglobulin M [IgM] | 5 |
| D80.5 | Immunodeficiency with increased immunoglobulin M [IgM] | 5 |
| D80.6 | Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia | 5 |
| D80.7 | Transient hypogammaglobulinemia of infancy | 5 |
| D81.0 | Severe combined immunodeficiency [SCID] with reticular dysgenesis | 5 |
| D81.1 | Severe combined immunodeficiency [SCID] with low T- and B-cell numbers | 5 |
Showing 10 of 1,433. The full list, non-covered diagnoses and CSV export are in Caduvo.
What changed for J1599
- 2011-01-01: J1599 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1599?
J1599 is the HCPCS Level II code for injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg. Short descriptor: "Ivig non-lyophilized, nos".
How much does Medicare pay for J1599?
In 2023, the average Medicare payment was $83.79 per service (average allowed $105.23).
Does Medicare cover J1599?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Which diagnoses support coverage for J1599?
Medicare policy articles that cite J1599 list 1,433 covered ICD-10-CM diagnosis codes across 6 articles. The most cited include D69.3 (Immune thrombocytopenic purpura), D80.0 (Hereditary hypogammaglobulinemia), D80.2 (Selective deficiency of immunoglobulin A [IgA]). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
How many units of J1599 can be billed per day?
300 on DME suppliers; 300 on outpatient hospital claims; 300 on practitioner claims (NCCI medically unlikely edits).
Related J15 codes
- J1551 — Injection, immune globulin (cutaquig), 100 mg
- J1552 — Injection, immune globulin (alyglo), 500 mg
- J1553 — Injection, immune globulin (yimmugo), 100 mg
- J1554 — Injection, immune globulin (asceniv), 500 mg
- J1555 — Injection, immune globulin (cuvitru), 100 mg
- J1556 — Injection, immune globulin (bivigam), 500 mg
- J1557 — Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1558 — Injection, immune globulin (xembify), 100 mg
- J1559 — Injection, immune globulin (hizentra), 100 mg
- J1560 — Injection, gamma globulin, intramuscular, over 10 cc
- J1561 — Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
- J1562 — Injection, immune globulin (vivaglobin), 100 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1599
- Watch J1599 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1599
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.